Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
Danaher reported third-quarter core revenue growth of 5.5%, excluding respiratory revenue, and a nearly 30% adjusted operating profit margin. It raised full-year adjusted diluted EPS guidance to $8.57–$8.62 and expects fourth-quarter core revenue growth, excluding respiratory revenue, of 4%–5%.
Intuitive Surgical reported Q3 2026 revenue growth of 22% to over $3 billion, alongside 15% growth in total procedures and 28% growth in da Vinci system placements. The company also plans to reduce da Vinci instruments and accessories revenue per procedure by 3% to 5%.
For best results when printing this announcement, please click on link below: ImmunityBio Reports Phase 3 Data Showing 84% Cystectomy Avoidance at Three Years and Complete Responses Beyond 53 Months with ANKTIVA(® )Plus BCG in BCG-Unresponsive NMIBC With CIS, With or Without Papillary Tumors Peer-reviewed publication r
For best results when printing this announcement, please click on link below: Safi Silver Corp. Reports Positive First Drill Results from the Addana Project in Morocco - Intercepts 657 g/t Ag — Safi Silver Corp. (TSX-V: SF; OTCPK: PNTZF) (“Safi Silver” or the “Company”) today reports the first assay results from its in
For best results when printing this announcement, please click on link below: FDA Expands ANKTIVA(® )Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease Expanded indication extends ANKTIVA plus BCG to patients with BCG-unresponsive non-muscle-invasive bladder cancer
Arcturus Therapeutics said enrollment is complete and all participants have finished study-drug dosing in its ARCT810 Phase 2 trial for OTC deficiency. The company expects to report clinical data in Q3 2026.
Valneva reported first-half 2026 product sales of €64 million, down from €91 million a year earlier, and maintained its 2026 guidance for product sales and total revenue.
SINTX Technologies reported second-quarter 2026 revenue of $452,000, up 199% year over year. It projected third- and fourth-quarter total revenue of $900,000 to $1.3 million, subject to production and customer scheduling uncertainties.
For best results when printing this announcement, please click on link below: SSR Mining Announces the Acquisition of Roxmore Resources Complementary Strategic Transaction Further Enhances The Future Of Ssr Mining’s Us Platform Roxmore’s Multi-million Ounce Converse Project Is Located Six Kilometers From The Marigold C
Inogen reported second-quarter revenue of $95.1 million, up 3% year over year, and adjusted EBITDA of $2.4 million, up 15%. The company lowered full-year 2026 revenue guidance to $355-$361 million and raised adjusted EBITDA guidance to $4 million.
Xenon Pharmaceuticals (NASDAQ: XENE ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call a
On Thursday, Denali Therapeutics (NASDAQ: DNLI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Denali Therapeutics reported a succ
On Thursday, Lineage Cell Therapeutics (AMEX: LCTX ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Lineage Ce
On Thursday, Cytokinetics (NASDAQ: CYTK ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Cytokinetics reported strong commercial momentum for Myc
Senseonics Holdings (AMEX: SENS ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Senseonics Holding
On Thursday, CVRx (NASDAQ: CVRX ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary CVRx reported a 16% year-over-year revenue growth in Q2 2026
INmune Bio (NASDAQ: INMB ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary INmune Bio's net loss for Q2 2026 was reduced to $1.3 m
Solstice Advanced Materials said it plans to invest $49 million to expand research and development capabilities at its Buffalo, New York facility. The company also said the project is supported by up to $1.4 million in performance-based tax credits and includes 12 new full-time jobs by June 2027.
Sotera Health (NASDAQ: SHC ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary Full Transcript OPERATOR Good morn
Eli Lilly (NYSE: LLY ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Full Transcript OPERATOR Ladies and gentlemen, thank you f
ImmunityBio said Dr. Patrick Soon-Shiong will take part in a fireside chat at Piper Sandler's Virtual Oncology Symposium on Oct. 16. The company also highlighted progress on ANKTIVA and its broader immunotherapy pipeline.
Aurora Cannabis (TSX: ACB ) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Aurora Cannabis Inc. reported a
Neogen said at its 2026 Investor Day that it plans to boost R&D, expand product innovation and target higher margins by fiscal 2031. The company also reiterated a framework for high-single-digit to low-double-digit revenue growth and a 30% adjusted EBITDA margin by FY2031.
Novavax (NASDAQ: NVAX ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Full Transcript Jim,
RPX Gold announced assay results from 12 drill holes totaling 2,051 metres at its Wawa Gold Project in Ontario. The company reported extensions of high-grade gold mineralization, including an intersection of 25.50 g/t gold over 4.26 metres, including 135.00 g/t gold over 0.71 metres.
On Thursday, Zoetis (NYSE: ZTS ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Zoetis reported a 1% decline i
Delcath Systems (NASDAQ: DCTH ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Delcath Syste
Amylyx Pharma (NASDAQ: AMLX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Amylyx Pharma re
Niagen Bioscience (NASDAQ: NAGE ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Niagen Bioscience Inc. reported
Meta Platforms (NASDAQ: META ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Meta Platform